Cited by 293Lipid metabolism and biosynthesisAdipose Tissue and MetabolismPeroxisome Proliferator-Activated Receptors

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Direct Effect of Glucocorticoids on Lipolysis in Adipocytes

Open access

Abstract

Hypercortisolemia and glucocorticoid treatment cause elevated level of circulating free fatty acids (FFAs). The basis of this phenomenon has long been linked to the effect of glucocorticoids permitting and enhancing the adipose lipolysis response to various hormones. In this study, we demonstrate that glucocorticoids directly stimulate lipolysis in rat primary adipocytes in a dose- and time-responsive manner; this lipolytic action was attenuated by treatment with the glucocorticoid antagonist RU486. Dexamethasone down-regulates mRNA and protein levels of cyclic-nucleotide phosphodiesterase 3B, thereby elevating cellular cAMP production and activating protein kinase A (PKA). On inhibition of PKA but not other kinases, the lipolysis response ceases. Furthermore, dexamethasone induces phosphorylation and down-regulation of perilipin, a lipid droplet-associating protein that modulates lipolysis; this effect is restored by RU486 or PKA inhibitor H89. Dexamethasone up-regulates mRNA and protein levels of hormone-sensitive lipase (HSL) and adipose triglyceride lipase; these effects, parallel to increased lipolysis, are attenuated by RU486 or actinomycin D. Phosphorylation at Ser-563 and Ser-660 residues of HSL and activity of cellular lipases are elevated on dexamethasone stimulation but abrogated by the coaddition of H89. However, dexamethasone does not induce HSL translocation to the lipid droplet surface in differentiated adipocytes. We show that elevated FFA concentration in plasma is associated with increased lipase activity and lipolysis in vivo in adipose tissues of dexamethasone-treated rats. Therefore, the lipolytic action of glucocorticoids liberates FFA efflux from adipocytes to the bloodstream, which could be a cellular basis of systemic FFA elevation in response to glucocorticoid challenge.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/me.2008-0464

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

Sorted by citations

Metadata

Authors
Xu, C., He, J., Jiang, H., Zu, L., Zhai, W., Pu, S., & Xu, G.
Affiliations
  • Peking University (CN)
  • Zhengzhou University (CN)
Corresponding author
Xu, Guoheng
Venue
Molecular Endocrinology
Published
2009-08
Volume
23
Issue
8
Pages
1161-1170
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W2115274616
Cited by
291
References
46
Citations by year
2026: 12 · 2025: 13 · 2024: 22 · 2023: 22 · 2022: 14 · 2021: 20 · 2020: 21 · 2019: 20 · 2018: 16 · 2017: 26 · 2016: 22 · 2015: 16 · 2014: 16 · 2013: 17 · 2012: 17
FWCI
6.00
Type
journal article
Language
en
Open access
Locations
  • Molecular Endocrinology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Pittsburgh
  • National Natural Science Foundation of China (30770803, 30890042, 30670779)
  • Peking University
  • National Key Research and Development Program of China (2006CB 503910, 2009CB941603)
  • Peking University Health Science Center
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
glucocorticoids, dexamethasone, adipocyte lipolysis, free fatty acids, cyclic AMP, protein kinase A, PDE3B, perilipin, hormone-sensitive lipase, adipose triglyceride lipase, hypercortisolism, RU486, H89, lipid droplets
MeSH terms
Adipose Tissue, Animals, Dexamethasone, Dose-Response Relationship, Drug, Enzyme Inhibitors, Glucocorticoids, Isoquinolines, Lipolysis, Male, Models, Biological, Serine, Sulfonamides, Rats, Sprague-Dawley, Adipocytes, Rats, Cyclic Nucleotide Phosphodiesterases, Type 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review